Robert A. Scott, Executive VP Research & Development at ATHEROGENICS INC (AGIX), bought 36,000 shares at $2.77 ($100K) on 2007-04-02, disclosed to the SEC on 2007-04-02.
Open-market purchase of $100k AGIX by Executive VP Research & Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| TEL | SELL | 2011-01-28 | $1.5M | — | Filing → |
| TEL | SELL | 2010-11-08 | $822K | — | Filing → |
| TEL | BUY | 2008-08-06 | $98K | — | Filing → |